EXOZYMES INC.
EXOZ · Biological Products, (No Diagnostic Substances) · 8.5M shares · +5%/yr ↑ dilution · EDGAR filings ↗
Reference price $10.53 · est. market cap ~$89M — last insider sale, 2026-04-09 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D40Clinical/early-stage biotech — engineered-enzyme biotech micro-cap, funded.
Strengths
- Liquidity — current ratio 2.5 (34th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Cash burnNegative free cash flow (-6.7M)
- Notable holderHeld by 1 notable fund(s): VANGUARD GROUP INC (as of 2025-12-31)
Key metrics
Return on equity
-269.6%
Return on assets
-153.4%
Current ratio
2.5×
Free cash flow
-$7M
Tangible book value
$3M
Cash & investments
$3M
Cash runway
2q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-09 | Korman Tyler Paz | Sell | 750 | $10.53 |
| 2026-04-08 | Korman Tyler Paz | Sell | 750 | $10.04 |
| 2026-04-01 | Perriman Damien Alan | Grant | 8.9K | $8.44 |
| 2026-04-01 | Opgenorth Paul Hideo | Grant | 4.0K | $8.44 |
| 2026-04-01 | Nawaz Fouad | Grant | 6.0K | $8.44 |
| 2026-04-01 | Korman Tyler Paz | Grant | 5.3K | $8.44 |
| 2026-04-01 | Perriman Damien Alan | Grant | 63K | — |
| 2025-07-02 | Heltzen Michael | Buy | 1.0K | $10.22 |
| 2025-06-16 | Korman Tyler Paz | Grant | 3.0K | $12.54 |
| 2025-06-13 | Opgenorth Paul Hideo | Grant | 3.0K | $12.54 |
| 2025-06-13 | Nawaz Fouad | Grant | 3.5K | $12.54 |
| 2025-01-17 | Heltzen Michael | Buy | 1.8K | $10.78 |
| 2025-01-16 | Heltzen Michael | Buy | 121 | $10.72 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-25 | 0001493152-26-030205 ↗ |
| 8-K | 2026-06-17 | 2026-06-17 | 0001493152-26-029119 ↗ |
| 8-K | 2026-06-08 | 2026-06-05 | 0001493152-26-027688 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001493152-26-023035 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001493152-26-021589 ↗ |
| 8-K | 2026-04-10 | 2026-04-10 | 0001493152-26-016227 ↗ |
| 8-K | 2026-03-31 | 2026-03-30 | 0001493152-26-013733 ↗ |
| 10-K | 2026-03-30 | 2025-12-31 | 0001493152-26-013563 ↗ |
| 8-K | 2026-02-05 | 2026-01-29 | 0001493152-26-005176 ↗ |
| 8-K | 2025-12-12 | 2025-12-11 | 0001493152-25-027327 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001493152-25-022289 ↗ |
| 8-K | 2025-11-13 | 2025-11-13 | 0001493152-25-022295 ↗ |